Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 41, 2021 - Issue 7
Submit an article Journal homepage
215
Views
5
CrossRef citations to date
0
Altmetric
Original Articles: Gynaecology

High grade, advanced, serous ovarian cancer with low serum CA125 levels

Aula Asalia Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel;b Sackler School of Medicine, Tel Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
,
Nasreen Haj-Yehiaa Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel;b Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Tania Zehavia Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel;b Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Talila Perrya Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel;b Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Mario Beinera Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel;b Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Ami Fishmana Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel;b Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
&
Yfat Kadana Department of Obstetrics and Gynecology, Meir Medical Center, Kfar Saba, Israel;b Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
 show all
Pages 1107-1111 | Published online: 11 Jan 2021

References

  • Cancer Genome Atlas Research Network. 2011. Integrated genomic analyses of ovarian carcinoma. Nature 474:609–615.
  • Cancer Today. 2020. International Agency for Research on Cancer. World Health Organization. Available from: http://gco.iarc.fr
  • Chéreau E, Ballester M, Selle F, Cortez A, Daraï E, Rouzier R. 2010. Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer. American Journal of Obstetrics and Gynecology 202:178.e1–178.e10.
  • Cooper BC, Sood AK, Davis CS, Ritchie JM, Sorosky JI, Anderson B, et al. 2002. Preoperative CA 125 levels: an independent prognostic factor for epithelial ovarian cancer. Obstetrics & Gynecology 100:59–64.
  • Das C, Mukhopadhyay M, Ghosh T, Saha AK, Sengupta M. 2014. Correlation of cytohistlogical expression and serum level of CA125 in ovarian neoplasm. Journal of Clinical and Diagnostic Research 8:41–43.
  • Gupta D, Lis CG. 2009. Role of CA125 in predicting ovarian cancer survival – a review of the epidemiological literature. Journal of Ovarian Research 2:13.
  • Høgdall EVS, Christensen L, Kjaer SK, Blaakaer J, Kjaerbye-Thygesen A, Gayther S, et al. 2007. CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish “MALOVA” Ovarian Cancer Study. Gynecologic Oncology 104:508–515.
  • Nonaka D, Chiriboga L, Soslow RA. 2008. Expression of Pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. The American Journal of Surgical Pathology 32:1566–1571.
  • Reinartz S, Failer S, Schuell T, Wagner U. 2012. CA125 (MUC16) gene silencing suppresses growth properties of ovarian and breast cancer cells. European Journal of Cancer (Oxford, England: 1990) 48:1558–1569.
  • Thériault C, Pinard M, Comamala M, Migneault M, Beaudin J, Matte I, et al. 2011. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. Gynecologic Oncology 121:434–443.
  • Xiang L, Kong B. 2013. PAX8 is a novel marker for differentiating between various types of tumor, particularly ovarian epithelial carcinomas. Oncology Letters 5:735–738.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.